{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T23:49:32Z","timestamp":1772063372391,"version":"3.50.1"},"reference-count":94,"publisher":"Portland Press Ltd.","issue":"2","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,1,1]]},"abstract":"<jats:p>Owing to the major limitations of current antiviral therapies in HBV (hepatitis B virus) infection, there is a strong need for novel therapeutic approaches to this major health burden. Stimulation of the host's innate and adaptive immune responses in a way that results in the resolution of viral infection is a promising approach. A better understanding of the virus\u2013host interaction in acute and chronic HBV infection revealed several possible novel targets for antiviral immunotherapy. In the present review, we will discuss the current state of the art in HBV immunology and illustrate how control of infection could be achieved by immunotherapeutic interventions.<\/jats:p>","DOI":"10.1042\/cs20120169","type":"journal-article","created":{"date-parts":[[2012,9,13]],"date-time":"2012-09-13T11:22:36Z","timestamp":1347535356000},"page":"77-85","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Hepatitis B virus: from immunobiology to immunotherapy"],"prefix":"10.1042","volume":"124","author":[{"given":"Daniel","family":"Grimm","sequence":"first","affiliation":[{"name":"Department of Medicine II, University of Freiburg, D-79106 Freiburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Heeg","sequence":"additional","affiliation":[{"name":"Department of Medicine II, University of Freiburg, D-79106 Freiburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Thimme","sequence":"additional","affiliation":[{"name":"Department of Medicine II, University of Freiburg, D-79106 Freiburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2012,9,12]]},"reference":[{"key":"2021113010244895900_B1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B","volume":"50","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J. Hepatol."},{"key":"2021113010244895900_B2","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/0016-5085(93)90664-X","article-title":"Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor","volume":"104","author":"Ilan","year":"1993","journal-title":"Gastroenterology"},{"key":"2021113010244895900_B3","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jhep.2009.12.017","article-title":"The molecular basis of the failed immune response in chronic HBV: therapeutic implications","volume":"52","author":"Maini","year":"2010","journal-title":"J. Hepatol."},{"key":"2021113010244895900_B4","article-title":"Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection","author":"Bertoletti","year":"2011","journal-title":"Gut"},{"key":"2021113010244895900_B5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"2021113010244895900_B6","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1128\/JVI.01022-08","article-title":"Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus","volume":"82","author":"Guy","year":"2008","journal-title":"J. Virol."},{"key":"2021113010244895900_B7","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010244895900_B8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000150418","article-title":"The woodchuck: an animal model for hepatitis B virus infection in man","volume":"38","author":"Roggendorf","year":"1995","journal-title":"Intervirology"},{"key":"2021113010244895900_B9","doi-asserted-by":"crossref","first-page":"9652","DOI":"10.1128\/JVI.00867-09","article-title":"The size of the viral inoculum contributes to the outcome of hepatitis B virus infection","volume":"83","author":"Asabe","year":"2009","journal-title":"J. Virol."},{"key":"2021113010244895900_B10","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010244895900_B11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1099\/vir.0.004861-0","article-title":"Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells","volume":"90","author":"Hantz","year":"2009","journal-title":"J. Gen. Virol."},{"key":"2021113010244895900_B12","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/j.gastro.2009.06.054","article-title":"Temporal analysis of early immune responses in patients with acute hepatitis B virus infection","volume":"137","author":"Dunn","year":"2009","journal-title":"Gastroenterology"},{"key":"2021113010244895900_B13","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/JVI.01844-08","article-title":"Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type\u00a01 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections","volume":"83","author":"Stacey","year":"2009","journal-title":"J. Virol."},{"key":"2021113010244895900_B14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3851\/IMP1620","article-title":"The host\u2013pathogen interaction during HBV infection: immunological controversies","volume":"15","author":"Bertoletti","year":"2010","journal-title":"Antiviral Ther."},{"key":"2021113010244895900_B15","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s12072-011-9261-3","article-title":"HBV life cycle and novel drug targets","volume":"5","author":"Grimm","year":"2011","journal-title":"Hepatol. Int."},{"key":"2021113010244895900_B16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jhep.2009.10.031","article-title":"The replication cycle of hepatitis B virus","volume":"52","author":"Urban","year":"2010","journal-title":"J. Hepatol."},{"key":"2021113010244895900_B17","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1128\/JVI.79.15.9369-9380.2005","article-title":"Stealth and cunning: hepatitis B and hepatitis C viruses","volume":"79","author":"Wieland","year":"2005","journal-title":"J. Virol."},{"key":"2021113010244895900_B18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.patbio.2009.11.001","article-title":"Pathogenesis of hepatitis B virus infection","volume":"58","author":"Chisari","year":"2010","journal-title":"Pathol. Biol."},{"key":"2021113010244895900_B19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jhep.2009.05.022","article-title":"Control of cccDNA function in hepatitis B virus infection","volume":"51","author":"Levrero","year":"2009","journal-title":"J. Hepatol."},{"key":"2021113010244895900_B20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.23230","article-title":"Control of hepatitis B virus replication by innate response of HepaRG cells","volume":"51","author":"Lucifora","year":"2010","journal-title":"Hepatology"},{"key":"2021113010244895900_B21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.chom.2011.05.001","article-title":"Innate DNA sensing moves to the nucleus","volume":"9","author":"Unterholzner","year":"2011","journal-title":"Cell Host Microbe"},{"key":"2021113010244895900_B22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1172\/JCI5048","article-title":"Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis","volume":"104","author":"Coffin","year":"1999","journal-title":"J. Clin. Invest."},{"key":"2021113010244895900_B23","doi-asserted-by":"crossref","first-page":"2074.e2","DOI":"10.1053\/j.gastro.2011.02.057","article-title":"Hepatitis B virus limits response of human hepatocytes to interferon-\u03b1 in chimeric mice","volume":"140","author":"Lutgehetmann","year":"2011","journal-title":"Gastroenterology"},{"key":"2021113010244895900_B24","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.23226","article-title":"Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection","volume":"50","author":"Hosel","year":"2009","journal-title":"Hepatology"},{"key":"2021113010244895900_B25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1128\/JVI.01825-10","article-title":"Hepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of \u03b2 interferon","volume":"85","author":"Kumar","year":"2011","journal-title":"J. Virol."},{"key":"2021113010244895900_B26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/cmi.2010.36","article-title":"Hepatitis B virus X protein suppresses virus-triggered IRF3 activation and IFN-\u03b2 induction by disrupting the VISA-associated complex","volume":"7","author":"Wang","year":"2010","journal-title":"Cell. Mol. Immunol."},{"key":"2021113010244895900_B27","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.4049\/jimmunol.0903874","article-title":"The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein","volume":"185","author":"Wei","year":"2010","journal-title":"J. Immunol."},{"key":"2021113010244895900_B28","doi-asserted-by":"crossref","first-page":"e1000986","DOI":"10.1371\/journal.ppat.1000986","article-title":"Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion","volume":"6","author":"Wang","year":"2010","journal-title":"PLoS Pathog."},{"key":"2021113010244895900_B29","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1099\/vir.0.020552-0","article-title":"Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated \u03b2 interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1\/IKK\u03f5 and DDX3","volume":"91","author":"Yu","year":"2010","journal-title":"J. Gen. Virol."},{"key":"2021113010244895900_B30","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/hep.22751","article-title":"Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells","volume":"49","author":"Wu","year":"2009","journal-title":"Hepatology"},{"key":"2021113010244895900_B31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/hep.21482","article-title":"Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein","volume":"45","author":"Visvanathan","year":"2007","journal-title":"Hepatology"},{"key":"2021113010244895900_B32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0168-8278(98)80206-7","article-title":"Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes","volume":"28","author":"Norris","year":"1998","journal-title":"J. Hepatol."},{"key":"2021113010244895900_B33","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1182\/blood-2009-08-238469","article-title":"Regulation of human NK-cell cytokine and chemokine production by target cell recognition","volume":"115","author":"Fauriat","year":"2010","journal-title":"Blood"},{"key":"2021113010244895900_B34","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10886-010-9801-7","article-title":"Influence of feeding and oviposition by phytophagous pentatomids on photosynthesis of herbaceous plants","volume":"36","author":"Velikova","year":"2010","journal-title":"J. Chem. Ecol."},{"key":"2021113010244895900_B35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.23977","article-title":"Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients","volume":"53","author":"Zhang","year":"2011","journal-title":"Hepatology"},{"key":"2021113010244895900_B36","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20061287","article-title":"Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage","volume":"204","author":"Dunn","year":"2007","journal-title":"J. Exp. Med."},{"key":"2021113010244895900_B37","doi-asserted-by":"crossref","first-page":"e1001227","DOI":"10.1371\/journal.ppat.1001227","article-title":"Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection","volume":"6","author":"Peppa","year":"2010","journal-title":"PLoS Pathog."},{"key":"2021113010244895900_B38","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1128\/JVI.02008-08","article-title":"Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells","volume":"83","author":"Guo","year":"2009","journal-title":"J. Virol."},{"key":"2021113010244895900_B39","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1128\/JVI.79.11.7269-7272.2005","article-title":"Toll-like receptor signaling inhibits hepatitis B virus replication in vivo","volume":"79","author":"Isogawa","year":"2005","journal-title":"J. Virol."},{"key":"2021113010244895900_B40","article-title":"Anti-viral efficacy and induction of an antibody response against surface antigen with the TLR7 agonist GS-9620\u00a0in the woodchuck model of chronic HBV infection","volume-title":"46th Annual Meeting of the European Association for the Study of the Liver","author":"Menne","year":"2011"},{"key":"2021113010244895900_B41","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(11)60267-5","article-title":"Genetic variation in biliary transporters as a susceptibility factor for cholangiocarcinoma","volume-title":"46th Annual Meeting of the European Association for the Study of the Liver","author":"Wadsworth","year":"2011"},{"key":"2021113010244895900_B42","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/MPG.0b013e3182447daf","article-title":"Resolution of parenteral nutrition associated jaundice on changing from a soya-oil emulsion to a complex mixed-lipid emulsion","volume":"54","author":"Muhammed","year":"2011","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"2021113010244895900_B43","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cellimm.2011.07.006","article-title":"Synergy between TLR3 and IL-18 promotes IFN-\u03b3 dependent TRAIL expression in human liver NK cells","volume":"271","author":"Tu","year":"2011","journal-title":"Cell. Immunol."},{"key":"2021113010244895900_B44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20072195","article-title":"TLR-dependent cross talk between human Kupffer cells and NK cells","volume":"205","author":"Tu","year":"2008","journal-title":"J. Exp. Med."},{"key":"2021113010244895900_B45","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1128\/JVI.01990-10","article-title":"Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibody","volume":"85","author":"Sastry","year":"2011","journal-title":"J. Virol."},{"key":"2021113010244895900_B46","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/gut.2008.163600","article-title":"Early kinetics of innate and adaptive immune responses during hepatitis B virus infection","volume":"58","author":"Fisicaro","year":"2009","journal-title":"Gut"},{"key":"2021113010244895900_B47","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8+ T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J. Virol."},{"key":"2021113010244895900_B48","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1084\/jem.193.7.847","article-title":"Kinetics of acute hepatitis B virus infection in humans","volume":"193","author":"Whalley","year":"2001","journal-title":"J. Exp. Med."},{"key":"2021113010244895900_B49","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1053\/jhep.2000.19324","article-title":"Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms","volume":"32","author":"Webster","year":"2000","journal-title":"Hepatology"},{"key":"2021113010244895900_B50","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.4049\/jimmunol.145.10.3442","article-title":"Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection","volume":"145","author":"Ferrari","year":"1990","journal-title":"J. Immunol."},{"key":"2021113010244895900_B51","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.33588\/rn.33S1.2001329","article-title":"Diagnosis of fragile X syndrome","volume":"33","author":"Glover","year":"2001","journal-title":"Rev. Neurol."},{"key":"2021113010244895900_B52","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nm0311-252","article-title":"A siege of hepatitis: immune boost for viral hepatitis","volume":"17","author":"Callendret","year":"2011","journal-title":"Nat. Med."},{"key":"2021113010244895900_B53","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4049\/jimmunol.177.1.739","article-title":"Circulating and liver resident CD4+CD25+ regulatory T-cells actively influence the antiviral immune response and disease progression in patients with hepatitis B","volume":"177","author":"Xu","year":"2006","journal-title":"J. Immunol."},{"key":"2021113010244895900_B54","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/hep.20649","article-title":"Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection","volume":"41","author":"Stoop","year":"2005","journal-title":"Hepatology"},{"key":"2021113010244895900_B55","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/JVI.79.6.3322-3328.2005","article-title":"Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection","volume":"79","author":"Franzese","year":"2005","journal-title":"J. Virol."},{"key":"2021113010244895900_B56","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4049\/jimmunol.0902761","article-title":"CD8+ T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions","volume":"184","author":"Phillips","year":"2010","journal-title":"J. Immunol."},{"key":"2021113010244895900_B57","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","author":"Guidotti","year":"1999","journal-title":"Science"},{"key":"2021113010244895900_B58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2893.2007.00911.x","article-title":"Hepatocyte turnover in transient and chronic hepadnavirus infections","volume":"14","author":"Mason","year":"2007","journal-title":"J. Viral Hepat."},{"key":"2021113010244895900_B59","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1172\/JCI43127","article-title":"Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity","volume":"120","author":"McMahan","year":"2010","journal-title":"J. Clin. Invest."},{"key":"2021113010244895900_B60","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/hep.22413","article-title":"Activation of hepatic stellate cells after phagocytosis of lymphocytes: a novel pathway of fibrogenesis","volume":"48","author":"Muhanna","year":"2008","journal-title":"Hepatology"},{"key":"2021113010244895900_B61","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"2007","journal-title":"J. Virol."},{"key":"2021113010244895900_B62","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1128\/JVI.78.11.5707-5719.2004","article-title":"Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy","volume":"78","author":"Webster","year":"2004","journal-title":"J. Virol."},{"key":"2021113010244895900_B63","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.191.8.1269","article-title":"The role of virus-specific CD8+ cells in liver damage and viral control during persistent hepatitis B virus infection","volume":"191","author":"Maini","year":"2000","journal-title":"J. Exp. Med."},{"key":"2021113010244895900_B64","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/jhep.2001.23045","article-title":"Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy","volume":"33","author":"Boni","year":"2001","journal-title":"Hepatology"},{"key":"2021113010244895900_B65","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1172\/JCI3731","article-title":"Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B","volume":"102","author":"Boni","year":"1998","journal-title":"J. Clin. Invest."},{"key":"2021113010244895900_B66","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0168-8278(03)00292-7","article-title":"Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B","volume":"39","author":"Boni","year":"2003","journal-title":"J. Hepatol."},{"key":"2021113010244895900_B67","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1172\/JCI33402","article-title":"Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection","volume":"118","author":"Lopes","year":"2008","journal-title":"J. Clin. Invest."},{"key":"2021113010244895900_B68","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1128\/JVI.00855-06","article-title":"Role of Bim in regulating CD8+ T-cell responses during chronic viral infection","volume":"80","author":"Grayson","year":"2006","journal-title":"J. Virol."},{"key":"2021113010244895900_B69","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1053\/j.gastro.2008.05.078","article-title":"Intrahepatic murine CD8 T-cell activation associates with a distinct phenotype leading to Bim-dependent death","volume":"135","author":"Holz","year":"2008","journal-title":"Gastroenterology"},{"key":"2021113010244895900_B70","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1172\/JCI200421593","article-title":"The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity","volume":"114","author":"Bowen","year":"2004","journal-title":"J. Clin. Invest."},{"key":"2021113010244895900_B71","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2009.09.052","article-title":"Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B","volume":"138","author":"Fisicaro","year":"2010","journal-title":"Gastroenterology"},{"key":"2021113010244895900_B72","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.21965","article-title":"Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance","volume":"47","author":"Diehl","year":"2008","journal-title":"Hepatology"},{"key":"2021113010244895900_B73","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.immuni.2005.05.005","article-title":"Oscillating CD8+ T cell effector functions after antigen recognition in the liver","volume":"23","author":"Isogawa","year":"2005","journal-title":"Immunity"},{"key":"2021113010244895900_B74","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1074-7613(04)00050-0","article-title":"B7-H1 determines accumulation and deletion of intrahepatic CD8+ T lymphocytes","volume":"20","author":"Dong","year":"2004","journal-title":"Immunity"},{"key":"2021113010244895900_B75","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/hep.23173","article-title":"Chronically inflamed livers up-regulate expression of inhibitory B7 family members","volume":"50","author":"Kassel","year":"2009","journal-title":"Hepatology"},{"key":"2021113010244895900_B76","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"2021113010244895900_B77","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.4049\/jimmunol.178.5.2714","article-title":"PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver","volume":"178","author":"Maier","year":"2007","journal-title":"J. Immunol."},{"key":"2021113010244895900_B78","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1200\/JCO.2009.26.7609","article-title":"Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates","volume":"28","author":"Brahmer","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"2021113010244895900_B79","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.24249","article-title":"Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-prone CD8 T cells in persistent hepatitis B virus infection","volume":"53","author":"Schurich","year":"2011","journal-title":"Hepatology"},{"key":"2021113010244895900_B80","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/hep.23936","article-title":"The immunoregulatory role of CD244\u00a0in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function","volume":"52","author":"Raziorrouh","year":"2010","journal-title":"Hepatology"},{"key":"2021113010244895900_B81","doi-asserted-by":"crossref","first-page":"e1002045","DOI":"10.1371\/journal.ppat.1002045","article-title":"Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells","volume":"7","author":"Schlaphoff","year":"2011","journal-title":"PLoS Pathog."},{"key":"2021113010244895900_B82","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2009.06.074","article-title":"Regulation of protein kinase C isozymes during early postnatal hippocampal development","volume":"1288","author":"Purkayastha","year":"2009","journal-title":"Brain Res."},{"key":"2021113010244895900_B83","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1084\/jem.20072076","article-title":"Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection","volume":"205","author":"Das","year":"2008","journal-title":"J. Exp. Med."},{"key":"2021113010244895900_B84","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.4049\/jimmunol.121.4.1279","article-title":"Regulation of human lymphocyte function by a soluble extract from normal human liver","volume":"121","author":"Chisari","year":"1978","journal-title":"J. Immunol."},{"key":"2021113010244895900_B85","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nm866","article-title":"Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo","volume":"9","author":"Blattman","year":"2003","journal-title":"Nat. Med."},{"key":"2021113010244895900_B86","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.immuni.2010.04.014","article-title":"TGF-\u03b2 to the rescue","volume":"32","author":"Shevach","year":"2010","journal-title":"Immunity"},{"key":"2021113010244895900_B87","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbr.2008.02.039","article-title":"Glial alterations in the hippocampus of rats submitted to ibotenic-induced lesion of the nucleus basalis magnocellularis","volume":"190","author":"Swarowsky","year":"2008","journal-title":"Behav. Brain Res."},{"key":"2021113010244895900_B88","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.immuni.2009.06.015","article-title":"Cell-intrinsic transforming growth factor-\u03b2 signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo","volume":"31","author":"Tinoco","year":"2009","journal-title":"Immunity"},{"key":"2021113010244895900_B89","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1172\/JCI44198","article-title":"IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B","volume":"121","author":"Publicover","year":"2011","journal-title":"J. Clin. Invest."},{"key":"2021113010244895900_B90","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jhep.2010.12.031","article-title":"Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges","volume":"54","author":"Michel","year":"2011","journal-title":"J. Hepatol."},{"key":"2021113010244895900_B91","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jhep.2010.10.025","article-title":"Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines","volume":"55","author":"Gehring","year":"2011","journal-title":"J. Hepatol."},{"key":"2021113010244895900_B92","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/hep.23150","article-title":"Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models","volume":"50","author":"Deng","year":"2009","journal-title":"Hepatology"},{"key":"2021113010244895900_B93","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0168-8278(97)80363-7","article-title":"Hepatitis B associated liver failure following bone marrow transplantation","volume":"27","author":"Caselitz","year":"1997","journal-title":"J. Hepatol."},{"key":"2021113010244895900_B94","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0016-5085(91)90599-G","article-title":"Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study","volume":"100","author":"Lok","year":"1991","journal-title":"Gastroenterology"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/124\/2\/77\/441777\/cs1240077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/124\/2\/77\/441777\/cs1240077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T12:48:03Z","timestamp":1744116483000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/124\/2\/77\/69061\/Hepatitis-B-virus-from-immunobiology-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,12]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,1,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20120169","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,12]]}}}